• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同人群女性中炔雌醇的药代动力学。

Pharmacokinetics of ethynyloestradiol in women for different populations.

作者信息

Fotherby K, Akpoviroro J, Abdel-Rahman H A, Toppozada H K, de Souza J C, Coutinho E M, Koetsawang S, Nukulkarn P, Sheth U K, Mapa M K, Gopalan S, Plunkett E R, Brenner P F, Hickey M V, Grech E S, Lichtenberg R, Gual C, Molina R, Gomez-Rogers C, Kwon E, Kim S W, Chan T, Ratnam S S, Landgren B M, Shearman R P, Goldzieher J W, Dozier T S

出版信息

Contraception. 1981 May;23(5):487-96. doi: 10.1016/0010-7824(81)90076-7.

DOI:10.1016/0010-7824(81)90076-7
PMID:7285572
Abstract

The pharmacokinetics of a dose of 50 microgram ethynyloestradiol administered orally was studied in fourteen centres. Absorption was rapid and the highest serum concentrations of total ethynyloestradiol were found in most subjects at 1 h and by 24 h concentrations were less than 250 pg/ml. Calculation of the half-lives for absorption, distribution and elimination showed wide variations between subjects, the half-life of elimination varying from 2.5 h to more than 30 h. Bioavailability as measured by the area under the serum ethynyloestradiol concentration-time curve also showed more than a ten-fold variation. Intra-centre differences in the various parameters measured were as large as the inter-centre differences.

摘要

在14个中心研究了口服50微克乙炔雌二醇剂量的药代动力学。吸收迅速,大多数受试者在1小时时总乙炔雌二醇的血清浓度最高,到24小时时浓度低于250 pg/ml。吸收、分布和消除半衰期的计算显示受试者之间差异很大,消除半衰期从2.5小时到超过30小时不等。通过血清乙炔雌二醇浓度-时间曲线下面积测量的生物利用度也显示出超过10倍的差异。各中心测量的各种参数的中心内差异与中心间差异一样大。

相似文献

1
Pharmacokinetics of ethynyloestradiol in women for different populations.不同人群女性中炔雌醇的药代动力学。
Contraception. 1981 May;23(5):487-96. doi: 10.1016/0010-7824(81)90076-7.
2
Pharmacokinetics of norethisterone in humans.
Contraception. 1987 May;35(5):465-75. doi: 10.1016/0010-7824(87)90083-7.
3
Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.
Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):318-22. doi: 10.1016/0002-9378(90)90575-r.
4
Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.低剂量口服避孕药在接受腹膜透析的慢性肾衰竭女性中的单剂量和多剂量药代动力学。
Am J Obstet Gynecol. 1993 May;168(5):1400-6. doi: 10.1016/s0002-9378(11)90772-8.
5
Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
Contraception. 1983 Sep;28(3):241-51. doi: 10.1016/0010-7824(83)90065-3.
6
Pharmacokinetics of ethynyloestradiol in humans.
Methods Find Exp Clin Pharmacol. 1982;4(2):133-41.
7
Variability of pharmacokinetic parameters for contraceptive steroids.
J Steroid Biochem. 1983 Jul;19(1C):817-20. doi: 10.1016/0022-4731(83)90017-1.
8
An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
Contraception. 1979 Sep;20(3):263-73. doi: 10.1016/0010-7824(79)90098-2.
9
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.口服去氧孕烯的血清药代动力学及避孕孕激素与性激素结合球蛋白的结合
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 2):2132-7. doi: 10.1016/0002-9378(90)90553-j.
10
Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.囊性纤维化患者中避孕甾体激素的药代动力学
Thorax. 1987 Jan;42(1):59-64. doi: 10.1136/thx.42.1.59.

引用本文的文献

1
Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: A Systematic review.接受抗逆转录病毒治疗的HIV感染女性使用激素避孕方法:一项系统评价。
Open Access J Contracept. 2015;6:37-520. doi: 10.2147/OAJC.S55038. Epub 2015 May 7.
2
Drug interactions between hormonal contraceptives and antiretrovirals.激素避孕药与抗逆转录病毒药物之间的药物相互作用。
AIDS. 2017 Apr 24;31(7):917-952. doi: 10.1097/QAD.0000000000001392.
3
Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.
延长周期方案中炔雌醇和屈螺酮的药代动力学特征:一项随机III期研究的群体药代动力学分析
J Fam Plann Reprod Health Care. 2013 Apr;39(2):e1-13. doi: 10.1136/jfprhc-2012-100397.
4
Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women.屈螺酮和炔雌醇在高加索及日本女性中的药代动力学
Eur J Contracept Reprod Health Care. 2012 Aug;17(4):284-97. doi: 10.3109/13625187.2012.677076. Epub 2012 Jun 10.
5
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.涉及17α-乙炔雌二醇的药代动力学药物相互作用:对一种老药的新审视。
Clin Pharmacokinet. 2007;46(2):133-57. doi: 10.2165/00003088-200746020-00003.
6
Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.育龄期女性癫痫的治疗:药代动力学考量
Clin Pharmacokinet. 2002;41(8):559-79. doi: 10.2165/00003088-200241080-00002.